BioLegend

Uses your system voice; voice and rate in settings.

Q4914628Snapshot

≈ 2 min read

Names in other languages

  • العربيةشركة بايوليجند
  • DeutschBioLegend
  • EnglishBioLegend
  • EspañolBioLegend
  • FrançaisBioLegend
  • ItalianoBioLegend
  • NederlandsBioLegend
  • 中文BioLegend

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

BioLegend is a global developer and manufacturer of antibodies and reagents used in biomedical research located in San Diego, California. It was incorporated in June 2002 and has since expanded to include BioLegend Japan KK, where it is partnered with Tomy Digital Biology Co., Ltd. in Tokyo, BioLegend Europe in the United Kingdom, BioLegend GmbH in Germany, and BioLegend UK Ltd in the United Kingdom.

In July 2021, BioLegend was acquired by PerkinElmer for $5.25 billion and now operates as Revvity. BioLegend manufactures products in the areas of neuroscience, cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies.

Reagents are created for use in flow cytometry, proteogenomics, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays.

BioLegend is a global developer and manufacturer of antibodies and reagents used in biomedical research located in San Diego, California. It was incorporated in June 2002 and has since expanded to include BioLegend Japan KK, where it is partnered with Tomy Digital Biology Co., Ltd. in Tokyo, BioLegend Europe in the United Kingdom, BioLegend GmbH in Germany, and BioLegend UK Ltd in the United Kingdom.

In July 2021, BioLegend was acquired by PerkinElmer for $5.25 billion and now operates as Revvity. BioLegend manufactures products in the areas of neuroscience, cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies.

Reagents are created for use in flow cytometry, proteogenomics, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1359474979 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot biolegend-561023-277299e3054ae3b6 · hash 277299e3054ae3b6d6784b578189033a53d2be24e6996a8c543f5f700bee5712 · captured 1781524315.0 · version history

Cite this page as: encyclopegia.org, “BioLegend”, snapshot biolegend-561023-277299e3054ae3b6. https://encyclopegia.org/a/biolegend

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.